Improving cancer outcomes and leadership course: a European initiative - Block 2
Improving cancer outcomes and leadership course: a European initiative - Block 2
Arrivals - Check in and Registration
Welcome and Introduction
Session 1: Overview of strategic approaches to improve Europe’s cancer outcomes and what it means
Discussion
Peter Selby (UK)Session 2: 1st cohort - Update on initiatives and challenges to improve clinical practice
Implementing the European Code of Cancer Practice in Rural and Remote European Communities
David Nelson (UK)Breast cancer pathway creation and implementation
Assia Konsoulova (BG)Q&A
Alexandru Eniu (CH)Coffee break
Session 3: Strategic Approaches to Oncopolicy
Strategies in other Countries - use of resources, share of clinical burden
Richard Sullivan (UK)Case Study - Launching lung screening programmes in Europe
Miroslav Samarzija (HR)Discussion
Alberto Costa (IT)Session 4: Effective and Equitable Cancer Care
Factors Determining Effective and Equitable Cancer Care
Ajay Aggarwal (UK)Implementation and hurdles of applying factors in the clinic
Alexandru Eniu (CH)Discussion
Razvan Popescu (CH)Lunch
Session 5 - Survivorship and reintegration
Survivorship and reintegration
Tanja Spanic (SI)Discussion
Kathy Oliver (UK)Parallell Workshops: Leadership
Leadership - Group 1
Caroline Lark (UK)Influencing & Negotiating - Group 2
Lynda Holt (UK)Coffee break
Parallell Workshops: Leadership
Leadership - Group 2
Caroline Lark (UK)Influencing & Negotiating - Group 1
Lynda Holt (UK)Evening: free to explore Zagreb
Session 6 - Value-based Clinical Decision Making
Clinical View
Alexandru Eniu (CH)Health Systems View
Richard Sullivan (UK)Discussion
Mark Lawler (UK)Session 7: Improving Efficiency in Cancer Care
Improving Efficiency in Cancer Care
Matt Hickey (UK)Discussion
Eduardo Pisani (BE)Coffee break
BREAKOUT SESSION 1 - Partcipant presentations of initiatives and challenges to improve outcomes
Blue Group
Red Group
Green Group
Lunch
Session 8: Overview the impact of emerging technologies on how we approach planning cancer services
Overview the impact of emerging technologies on how we approach planning cancer services
Andrea Pace (IT)Discussion
Mark Lawler (UK)BREAKOUT SESSION 2 - Partcipant presentations of initiatives and challenges to improve outcomes
Blue Group
Red Group
Green Group
Coffee break
BREAKOUT SESSION 3 - Partcipant presentations of initiatives and challenges to improve outcomes
Blue Group
Red Group
Green Group
Dinner in hotel
Advice Clinics
How to use Patient Advocacy
Kathy Oliver (UK) Tanja Spanic (SI)Commercial partnerships to utilize big data analysis for patient benefit
Matt Hickey (UK) Mark Lawler (UK) Maheva Vallet (UK)Establishing quality multidisciplinary/multi professional interactions
Alexandru Eniu (CH) Assia Konsoulova (BG) Razvan Popescu (CH)Advice Clinics
How to use Patient Advocacy
Kathy Oliver (UK) Tanja Spanic (SI)Commercial partnerships to utilize big data analysis for patient benefit
Matt Hickey (UK) Mark Lawler (UK) Maheva Vallet (UK)Establishing quality multidisciplinary/multi professional interactions
Alexandru Eniu (CH) Assia Konsoulova (BG) Razvan Popescu (CH)Coffee break
Special session: Comprehensive Cancer Centers
The concept of Comprehensive Cancer Centers: Romanian example
Alexandru Eniu (CH)The concept of Comprehensive Cancer Centers: Slovenian example
Tit Albreht (SI)International and national initiatives to bring the concept of a (National) Comprehensive Cancer Center to Croatia
Steven Pavletic (US) Stjepko Pleština (HR)Discussion
Stjepko Pleština (HR)Improving Cancer Outcomes Award
Closing remarks and departures
Ajay Aggarwal
London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Alberto Costa
European School of Oncology, Director's Office, Milano, IT
Alexandru Eniu
Riviera-Chablais Hospital, Medical Oncology Dpt., Rennaz, CH/RO
Andrea Pace
IRCCS Regina Elena Cancer Institute, Neurooncology Unit, Rome, IT
Assia Konsoulova
National Cancer Hospital, Medical Oncology Clinic, Sofia, BG
Caroline Lark
Talent for Growth Ltd, ., Tavistock, Devon, UK
David Nelson
University of Lincoln, Health Dpt., Lincoln, UK
Eduardo Pisani
All.Can International, CEO, Brussels, BE
Kathy Oliver
International Brain Tumour Alliance - IBTA, Patient Advocacy Dept., Tadworth, Surrey, UK
Lynda Holt
Health Service 360, CEO, Stratford upon Avon, UK
Maheva Vallet
University of Edinburgh, Edinburgh Cancer Informatics, Edinburgh, UK
Mark Lawler
Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Matt Hickey
The Health Value Alliance, Management Dept., Epsom, UK
Miroslav Samarzija
Clinical Hospital Center Zagreb, Department of Pulmonary Diseases, Zagreb, HR
Peter Selby
Lincoln, UK
Razvan Popescu
Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Richard Sullivan
King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK
Steven Pavletic
Bethesda, Maryland, US
Stjepko Pleština
University Hospital Centre Zagreb, Oncology Department, Zagreb, HR
Tanja Spanic
Europa Donna Slovenia, Patient Advocacy Dpt., Ljubljana, SI
Tit Albreht
National Institute of Public Health, ., Ljubljana, SI
